Guest guest Posted October 4, 2005 Report Share Posted October 4, 2005 " HSI - Jenny Thompson " <HSIResearch HSI e-Alert - What Would Hippocrates Do? Tue, 04 Oct 2005 07:00:00 -0400 HSI e-Alert - What Would Hippocrates Do? Health Sciences Institute e-Alert **************************************************** October 04, 2005 Dear Reader, How can you identify a Big Kahuna? Here's one way: They send down a pronouncement from on high and throw in a little Latin. In this case the Big Kahuna is Gabriella M. D'Andrea, M.D., an Assistant Clinical Member in the Department of Medicine at the Memorial Sloan-Kettering Cancer Center in New York City. The current issue of CA - an American Cancer Society journal - carries an article by Dr. D'Andrea titled " Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided. " The title says it all. In Dr. D'Andrea's opinion, the controversy over the effect of antioxidants on chemotherapy or radiation therapy is, for the moment, settled. And here's the Latin part. Dr. D'Andrea writes that doctors who use chemo or radiation " must be guided by existing data in the context of a fundamental principle of medicine, 'Primum non nocere.' " That zinger is from Hippocrates, and translates as: " First do no harm. " I wonder if Dr. D'Andrea appreciates the astonishing irony in suggesting that antioxidants are harmful while she advocates chemo and radiation, two of the most harmful therapies ever devised. And what would Hippocrates make of these therapies that are in supposed conflict with antioxidants? Maybe we can find a clue in another quote from the Father of Medicine: " Let thy food be thy medicine and medicine be thy food. " ----------- Man in the middle ----------- In a nutshell, here's how the controversy goes: Cytotoxic therapies (such as certain chemo and radiation therapies) create free radicals that are believed to help prompt the death of cancer cells. In the late 90s, a few researchers theorized that antioxidant supplements might make the therapies less successful. Some have even gone so far as to suggest that patients treated with cytotoxic therapies should avoid antioxidant-rich foods. This would basically cut all fruits and vegetables out of an ailing person's diet. What's wrong with THAT picture!? Dan Labriola, N.D., was one of the first researchers to theorize this antioxidant/cytotoxic conflict. In 1999, Dr. Labriola reported in the journal Oncology that patients who took antioxidant supplements had poorer responses to some cytotoxic therapies compared to patients who didn't use supplements. Dr. Labriola suddenly found himself in no-mans land. As a naturopathic physician he was not treated with respect by the mainstream, and with his anti-antioxidant position he was roundly denounced by the alternative medicine community. But the response from the alternative crowd wasn't a knee-jerk reaction. There was already quite a bit of evidence that antioxidants can be helpful in fighting cancer, even when used with cytotoxic therapies. ----------- Known territory ----------- Ralph W. Moss, Ph.D., is one of the foremost authorities on alternative cancer treatments. And I expect that Dr. Moss would have a serious bone to pick with Dr. D'Andrea. In 2000, Dr. Moss published a book titled " Antioxidants Against Cancer " in which he outlined the ways antioxidants actually ENHANCE the effectiveness of cytotoxic treatments while minimizing their side effects. And Dr. Moss' position is backed up by considerable research. For instance, a Life Extension Foundation (LEF) article published last year stated that Charles Simone, M.MS., M.D., has cited more than 350 studies that demonstrate how antioxidants have extended cancer patients' life spans while improving their quality of life. Dr. Simone is a medical and radiation oncologist who helped establish the Office of Alternative Medicine for the National Institutes of Health. The LEF article also featured a pioneer of nutritional healing and dietary supplement treatments, Abram Hoffer, M.D., Ph.D. Dr. Hoffer has used mega doses of vitamin C to successfully treat well over 1,000 cancer patients, most of whom were also receiving chemotherapy. ----------- She said, he said ----------- At a 2001 biomedical symposium, Dr. Moss gave a speech that included this comment: " We can reassure patients that the overwhelming mass of data accumulated so far supports the concurrent use of chemotherapy with dietary antioxidants. " As for supplementary antioxidants, HSI Panelist Allan Spreen, M.D., offers this outline of a cancer treatment regimen that includes a familiar antioxidant: " Most alternative doctors, whether they use chemo, modified chemo (a powerful technique called Insulin Potentiated Therapy, or IPT), or no chemo, nearly ALL utilize vitamin C in VERY high doses. The key is using it intravenously on non-chemo days, as it is used up very quickly in times of stress (cancer would more than qualify). Chemo acts fairly quickly, and the vitamin C tends to protect normal cells more than cancer cells, which it helps to kill in many cases; a fact well-established by Dr. Hugh Riordan at his clinic in Wichita, KS. " And Dr. Spreen adds: " I'd have to see a TON of highly definitive evidence before I'd stop taking supplements with my cancer treatment. " **************************************************** ....and another thing Good news: The sage researchers have saddled up. In the e-Alert " Riders of the Purple Sage " (9/29/05), I told you that an important Alzheimer's disease (AD) study that was slated to start two months ago had not yet started enrolling subjects. But it appears that the National Institutes of Health (NIH) web site that has info about the study isn't quite up to date. The research is sponsored by the National Center for Complementary and Alternative Medicine (NCCAM - part of the NIH), and it's being conducted at Oregon Health and Science University in Portland. So I sent an e-mail to Kristin Flegal at OHSU and she quickly responded. Kristin writes: " The sage study is now underway. The project is funded for two years, during which time we will be collecting and analyzing data. We are continuing to recruit study participants from the Portland area. A total of 40 AD patients will be enrolled. " According to the NIH web site, the trial will last six weeks. Subjects who have been diagnosed with mild AD will be given sage extract or placebo during four phases of the study. Each phase will last 10 days. Outcomes will be measured with cognitive testing (attention, memory, visual cognition), and subjects will undergo an electroencephalogram (EEG) and an electrocardiogram (ECG) during the four phases. Caregivers for each of the subjects will also participate in the study, " to accompany participants to all study visits, provide informed consent, monitor participants' pill-taking, and communicate changes in participants' health during the study. " If you know someone in the Portland, OR, area who might be eligible, you can find more information at this site: clinicaltrials.gov/ct/show/NCT00110552. To Your Good Health, Jenny Thompson **************************************************** Sources: " Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided " Gabriella M. D'Andrea, M.D., CA - A Cancer Journal for Clinicians, American Cancer Society, Vol. 55, No. 5, September/October 2005, caonline.amcancersoc.org " Big Boost for Antioxidants " Ralph W. Moss, Ph.D., Cancer Decisions Newsletter Archives, 4/18/03, cancerdecisions.com " The Concurrent Use of Antioxidants and Cytotoxic Cancer Treatments " Ralph W. Moss, Ph.D., A Speech to the 7th International Symposium for Biologically Closed Electric Circuits in Biomedicine, July 2001, annieappleseedproject.org " Cancer: Should Patients Take Dietary Supplements? " Life Extension Foundation, 6/30/04, lef.org ******************** Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.